Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells

Drug Metabolism and Disposition

Volumn 27, Issue 5, 1999, Pages 569-573

  Münzel, Peter A ^b   Schmohl, Stefan ^b   Heel, Horst ^b   Kälberer, Katharina ^b   Bock Hennig, Barbara S ^b   Bock, Karl Walter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; GLUCURONOSYLTRANSFERASE; TERT BUTYLHYDROQUINONE;

ARTICLE; CELL STRAIN CACO 2; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME INDUCTION; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ANTIOXIDANTS; CACO-2 CELLS; ENVIRONMENTAL POLLUTANTS; ENZYME INDUCTION; GLUCURONOSYLTRANSFERASE; HUMANS; HYDROQUINONES; ISOENZYMES; TETRACHLORODIBENZODIOXIN;

EID: 0343249383     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bock KW (1991) Roles of UDP-glucuronosyltransferases in chemical carcinogenesis. CRC Crit Rev Biochem Mol Biol 26:129-150.
2. Bock KW, Forster A, Gschaidmeier H, Brück M, Münzel P, Schareck W, Fournel-Gigleux S and Burchell B (1993) Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem Pharmacol 45:1809-1814.
3. Boone CW, Kelloff GJ and Malone WE (1990) Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review. Cancer Res 50:2-9.
4. Buetler TM, Gallagher EP, Wang C, Stahl DL, Hayes JD and Eaton DL (1995) Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol Appl Pharmacol 135:45-57.
5. Caro I, Boulenc X, Rousset M, Meunier V, Bourrie M, Julian B, Joyeux H, Roques C, Berger Y, Zweibaum A and Fabre G (1995) Characterisation of a newly isolated Caco-2 clone (TC-7), as a model of transport processes and biotransformation of drugs. Int J Pharm (Amst) 116:147-158.
6. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
7. Coffman BL, King CD, Rios GR and Tephly TR (1998) The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos 26:73-77.
8. Eaton DL, Gallagher EP, Bammler TK and Kunze KL (1995) Role of cytochrome P4501A2 in chemical carcinogenesis: Implications for human variability in expression and enzyme activity. Pharmacogenetics 5:259-274.
9. Ebner T and Burchell B (1993) Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab Dispos 21:50-55.
10. Franklin TJ, Jacobs V, Jones G, Plé P and Bruneau P (1996) Glucuronidation associated with intrinsic resistance to mycophenolic acid in human colorectal carcinoma cells. Cancer Res 56:984-987.
11. Gessner T, Vaughan LA, Beehler BC, Bartels CJ and Baker RM (1990) Elevated pentose cycle and glucuronosyltransferase in daunorubicin-resistant P388 cells. Cancer Res 50:3921-3927.
12. Gschaidmeier H, Seidel A, Oesch F, Burchell B and Bock KW (1995) Formation of mono-and diglucuronides and of other glycosides of benzo(a)pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Biochem Pharmacol 49:1601-1606.
13. Hankinson O (1995) The aryl hydrocarbon receptor complex. Anna Rev Pharmacol Toxicol 35:307-340.
14. Iyanagi T, Haniu M, Sogawa K, Fujii-Kuriyama Y, Watanabe S, Shively JE and Anan KF (1986) Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase. J Biol Chem 261:15607-15614.
15. Jaiswal AK (1994) Antioxidant response element. Biochem Pharmacol 48:439-444.
16. Jin C-J, Miners JO, Burchell B and Mackenzie PI (1993) The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. Carcinogenesis 14:2637-2639.
17. Lilienblum W, Bock-Hennig BS and Bock KW (1985) Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation on the quinol mono-and diglucuronide. Mol Pharmacol 27:451-458.
18. Lilienblum W, Walli AK and Bock KW (1982) Differential induction of rat liver microsomal UDP-glucuronyltransferase activities by various inducing agents. Biochem Pharmacol 31: 907-913.
19. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
20. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel-Gigleux S, Green M, Iyanagi T, Lancet D, Louisot P, Magdalou J, Roy Chowdhury J, Ritter JK, Schachter H, Tephly TR, Tipton KF and Nebert DW (1997) The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
21. Münzel PA, Bookjans G, Mehner G, Lehmköster T and Bock KW (1996) Tissue-specific TCDD-inducible expression of human UDP-glucuronosyltransferase UGT1A6. Arch Biochem Biophys 335:205-210.
22. Münzel PA, Brück M and Bock KW (1994) Tissue-specific constitutive and inducible expression of rat phenol UDP-glucuronosyltransferase. Biochem Pharmacol 47:1445-1448.
23. Münzel PA, Lehmköster T, Brück M, Ritter JK and Bock KW (1998) Aryl hydrocarbon receptor-inducible and constitutive expression of human UDP-glucuronosyltransferase UGT1A6. Arch Biochem Biophys 350:72-78.
24. Nebert DW (1991) Proposed role of drug-metabolizing enzymes: Regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol Endocrinol 5:1203-1214.
25. Nguyen T, Rushmore TH and Pickett CB (1994) Transcriptional regulation of a rat liver glutathione S-transferase Ya subunit gene. J Biol Chem 269:13656-13662.
26. Phillips CL, Lin LW, Wu JC, Guzman K, Milsted A and Miller WL (1988) 17β-Estradiol and progesterone inhibit transcription of the genes encoding the subunits of ovine follicle-stimulating hormone. Mol Endocrinol 2:641-649.
27. Pohl R and Fouts J (1980) A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal Biochem 107:150-155.
28. Prestera T and Talalay P (1995) Electrophile and antioxidant regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci USA 92:8965-8969.
29. Prochaska HJ and Talalay P (1988) Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res 48:4776-4782.
30. Reddy BS, Rao CV, Rivenson A and Kelloff G (1993) Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res 53:3493-3498.
31. Rossi GC, Brown GP, Leventhal L, Yang K and Pasternak GW (1996) Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia. Neurosci Lett 216:1-4.
32. Sies H (1993) Strategies of antioxidant defense. Eur J Biochem 215:213-219.
33. Strassburg CP, Manns MP and Tukey RH (1998) Expression of the UDP-glucuronosyltransferase 1A locus in human colon. J Biol Chem 273:8719-8726.
34. Sun X-Y, Plouzek CA, Henry JP, Wang TTY and Phang JM (1998) Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells. Cancer Res 58:2379-2384.
35. Sutter TR, Guzman K, Dold KM and Greenlee WF (1991) Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1β. Science (Wash) 254:415-418.
36. 1 gene. Proc Natl Acad Sci USA 93:14960-14965.
37. Walle T, Walle UK, Cowart TD, Conradi EC and Gaffney TE (1987) Selective induction of propranolol metabolism by smoking: Additional effects on renal clearance of metabolites. J Pharmacol Exp Ther 241:928-933.
38. Wasserman WW and Fahl WE (1997) Comprehensive analysis of proteins which interact with antioxidant responsive element: Correlation of ARE-BP-1 with the chemoprotective induction response. Arch Biochem Biophys 2:387-396.
39. Wattenberg LW (1983) Inhibition of neoplasia by minor dietary constituents. Cancer Res 43(Suppl):S2448-S2453.
40. Whitlock JP (1993) Mechanistic aspects of dioxin action. Chem Res Toxicol 6:754-763.